Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Boehringer Ingelheim
Express Scripts
Moodys
Colorcon

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Litigation Details for ALCON PHARMACEUTICALS LTD. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2015)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

ALCON PHARMACEUTICALS LTD. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-07-24
Court District Court, D. New Jersey Date Terminated 2018-09-26
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Douglas E. Arpert
Parties ALCON LABORATORIES, INC.; ALCON PHARMACEUTICALS LTD.; ALCON RESEARCH, LTD.; CIPRODEX; DR. REDDYS LABORATORIES, INC.; DR. REDDYS LABORATORIES, LTD.; PAR PHARMACEUTICAL, INC.; WATSON LABORATORIES, INC.
Patents 6,284,804; 6,359,016; 9,402,805
Attorneys ALAN HENRY POLLACK; CLIFFORD BRIAN KORNBREK; CYNTHIA STENCEL BETZ; ELEONORE OFOSU-ANTWI; JASON B. LATTIMORE; LIZA M. WALSH; MICHAEL W. CHOI; NICHOLAS M. INSUA; PETER LOUIS GIUNTA; PREETHA CHAKRABARTI; ROBERT M. GOODMAN; THOMAS KILEY MURPHY , III
Firms Crowell and Moring LLP; K & L Gates LLP; Law Office of Jason B. Lattimore, Esq.
Link to Docket External link to docket
Small Molecule Drugs cited in ALCON PHARMACEUTICALS LTD. v. DR. REDDYS LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for ALCON PHARMACEUTICALS LTD. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2017-06-27 135 regarding U.S. Patent Nos. 6,284,804 (“the ’804 patent”), 6,359,016 (“the ’016 patent”) and 9,402,805…Joint Claim Construction regarding U.S. Patent Nos. 6,284,804, 6,359,016 and 9,402,805. Signed by Judge… recited in the preamble of claim 1 of the 6,284,804 patent is to be given its plain, ordinary and customary… The Patent Family The Patents-In-Suit include the ’804 patent, the ’016 patent and the …the ’805 patent. The ’016 patent is a continuation1 of the ’804 patent, and as such shares the same specification External link to document
2016-10-13 67 AND ORDER Regarding Infringement re U.S. Patent Nos 6,284,804 and 6,359,016. Signed by Judge Peter G. … 26 September 2018 3:15-cv-05756 830 Patent None District Court, D. New Jersey External link to document
2017-01-27 87 MARKMAN OPENING BRIEF Regarding U.S. Patent No. 9,402,805 (Attachments: # 1 Declaration of M. Jayne… 26 September 2018 3:15-cv-05756 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Express Scripts
Mallinckrodt
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.